Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New heterocyclic chemopreventive agents described in U.S. patent

Jan. 30, 2001

Cel-Sci/NCI CRADA renewed and expanded

Jan. 30, 2001

Enrollment begins in phase III trial of Leuprogel 4-month for prostate cancer

Jan. 30, 2001

Production, development of recombinant mammastatin planned by Biotherapies

Jan. 30, 2001

Oxford BioMedica and AHP jointly develop novel antibody cancer therapy

Jan. 30, 2001

PBOX-6 shows potential for bypassing apoptotic suppressor Bcr-Abl in CML

Jan. 30, 2001

Geron regains rights to telomerase inhibitors from Pharmacia; forms new division

Jan. 30, 2001

Somatostatin and neuromedin B receptor agonists and their use

Jan. 29, 2001

New isocoumarins with antiangiogenic activity claimed by Korean scientists

Jan. 29, 2001

Selective aromatase inhibitors show promise in early or preventive breast cancer treatment

Jan. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...